丹红注射液治疗青年人急性脑梗死临床观察

Danhong Injection for Treatment of Young Patients with Acute Cerebral Infarction

目的观察丹红注射液对脑梗死的治疗效果。方法将72例脑梗死患者随机分为治疗组和对照组,每组36例。两组均予常规治疗,对照组加用复方丹参注射液治疗,治疗组加用丹红注射液治疗。观察治疗前后两组神经功能缺损评分变化及临床疗效。结果治疗组总有效率为97.22%,对照组为52.78%,两组比较差异有统计学意义(P<0.05);疗组治疗前后神经功能缺损评分分别为(20.86±1.15)分和(11.65±1.08)分(P<0.05),对照组分别为(21.13±1.01)分和(15.74±0.68)分(P<0.05),且治疗组和对照组治疗后比较差异有统计学意义(P<0.05)。结论丹红注射液对青年人脑梗死疗效明显。

Objective To study the efficacy of Danhong Injection for treatment of cerebral infarction. Methods Patients （pts） with cerebral infarction were divided into two groups randomly： Treatment group （n= 36） and control group （n= 36）. The pts in treatment group were treated by routine therapy with Danhong. The neural function defect score and clinical efficacy were analyzed before and after treatment and compared with that in control group. Results The total effective rates in treatmeni group and control group were 97.22 % and 52.78 %, respectively （P〈0.05）. The neural function defect scores in treatment group were 20.86 ± 1.15 and 11.65 ±1.08 pre and post treatment, respectively. Those in control group were 21.13± 1.01 and 15.74±0.68, respectively （P〈0. 05）. The neural function defect score in treatment group were improved significantly following treatment （P〈0.05）. Conclusion The Danhong Injection was effective for treatment of acute cerebral infarction.